Publication
Relevance of tumor markers for prognosis and predicting therapy response in non-small cell lung cancer patients: A CEPAC-TDM biomarker substudy.
Journal Paper/Review - Jan 1, 2024
Geiger Kimberly, Jörger Markus, Roessler Max, Hettwer Karina, Ritter Christoph, Simon Kirsten, Uhlig Steffen, Holdenrieder Stefan
Units
PubMed
Doi
Contact
Citation
Geiger K, Jörger M, Roessler M, Hettwer K, Ritter C, Simon K, Uhlig S, Holdenrieder S. Relevance of tumor markers for prognosis and predicting therapy response in non-small cell lung cancer patients: A CEPAC-TDM biomarker substudy. Tumour Biol 2024; 46:S191-S206.
Type
Journal Paper/Review (English)
Journal
Tumour Biol 2024; 46
Publication Date
Jan 1, 2024
Issn Electronic
1423-0380
Pages
S191-S206
Brief description/objective
Protein tumor markers are released in high amounts into the blood in advanced non-small cell lung cancer (NSCLC).